CBN

Meet Kiva’s Dream Team, CBN-infused sleep edibles for a great night’s rest

Published

1 year ago

February 28, 2023

admin

Camino Midnight Blueberry gummies are #1 sellers in a dreamy lineup of CBN-infused sleep products from Kiva.

Trouble sleeping is a common thread that tangles many. Lying awake, waiting for sleep that doesn’t come, waking up often, or rising for the day feeling unrested are all problems that plague a massive amount of people.

If you struggle with sleepless nights, it’s likely you’ve tried a whole host of potential remedies to quit counting sheep. From over-the-counter medications and supplements to exercise and white noise—if you’ve tried them all and still feel stuck, you’re not alone.

Cannabis strains for sleeping is one of the most popular effect categories on Leafly, with people looking for a natural remedy for sleeplessness turning to the power of the plant for solutions.

For many, cannabis edibles have become the secret to their better sleep success. Weed is a natural sedative and proven effective sleep aid for many people struggling with sleep-related issues. Cannabis-infused edibles carry the added benefit of staying in your system longer, providing an extra lift toward long-lasting sleep.

Now, top brands like Kiva are featuring CBN in sleep-targeting edible formulas to get a perfectly dialed dose of dreaminess. The rested reactions have been pouring in since 2019 when Kiva released the very first CBN sleep edible with their Camino Midnight Blueberry gummies: they’re not only Kiva’s best-selling gummy, but also the popular brand’s best-selling product by far.

“Aside from the fact that Kiva gummies are so delicious, [the Midnight Blueberry gummies] help me sleep like a baby. Wake up feeling refreshed too.”

Review on Leafly

Cannabis & CBN for sleeping

Luckily for those struggling with sleeplessness, studies show that cannabis can be an effective sleep aid. Many of the underlying problems influencing sleep issues like pain, racing thoughts, and insomnia, can be relieved by cannabis.

Sleep studies, primarily examining high-THC cannabis, have found that cannabis can help you fall asleep faster, and CBD has gotten attention for its sleep-aiding potential, especially in regard to its anxiety-relieving properties for people for whom anxiety plays a role in poor sleep.

Now CBN, another cannabinoid found naturally in the cannabis plant, is in the spotlight for its potential in aiding better sleep. The entourage effect in cannabis describes the phenomenon in which unique cannabinoids and terpenes in the plant work together to create distinct effects. Early indications suggest that CBN may work synergistically with THC and sedating terpenes to produce the sleep-inducing effects that people are searching for.

Kiva, no stranger to the front of the pack, was the first brand to release a CBN-infused edible back in 2019. Combining 5 mg THC with 1mg CBN and chamomile and lavender extract to provide a tailored, synergistic balance of cannabinoids and sleepy terpenes, Midnight Blueberry Camino gummies quickly became Kiva’s star product. Rested fans have been raving ever since, and Kiva has expanded its line of CBN-infused edibles to offer a range of ratios and flavors so that even more people can find relief.

The Kiva CBN Dream Team

Your sleep issues are unique to you, so it’s essential to have solutions that are tailored to your unique needs. Kiva developed the Dream Team to do just that, a lineup of CBN sleep edibles offering a spectrum of THC and CBN dosages, thoughtfully dreamy and delicious flavors, and formats from gummies to sours to chocolates to suit every taste.

Camino Sours Blackberry Dream

CBN-infused sleep edibles — Courtesy of Kiva

The latest in Kiva’s sleep lineup is also their strongest CBN-infused edible, with 10 mg THC and 3 mg CBN per gummy. These vegan gummies combine significant quantities of sedating cannabinoids and terpenes with dreamy blackberry flavors plus chamomile and lavender extract to offer a soothing experience to whisk you off to dreamland.

In thinking about dosages, it’s wise to consider your typical THC tolerance—cannabis will affect everyone differently so it’s important to experiment to find what works best for you—if you usually enjoy 10 mg THC edibles, the Camino Sours Blackberry Dream gummies are a great place to start.

Camino Midnight Blueberry sleep gummies

The sleepy spark that started it all, Camino Midnight Blueberry gummies contain 5 mg THC and 1 mg CBN. This sweet-spot dosage offers half the THC found in what’s generally considered a standard 10 mg THC potency for cannabis edibles. For people with lighter tolerance or who want a more balanced ratio of CBN to THC, this harmonious combo could be just the ticket to tranquil nights.

“These gummies are awesome. Take them an hour or two before bed. It’s a really nice body high that doesn’t get you stuck to the couch but does motivate you to get to bed.”

Review on Leafly

Midnight Mint Kiva Bar

For chocolate lovers or those seeking an extra boost of CBN, look no further than Kiva’s Midnight Mint Dark Chocolate Bar. With a soothing mix of 5 mg THC and 2 mg CBN per piece, these delectable bars have fans feeling rested and refreshed. Rich dark chocolate and crisp mint flavor with a sprinkling of cacao nibs make for a dessert you’ll look forward to almost as much as the sound sleep that comes after.

Terra Milk & Cookies Bites

If milk chocolate is more your style, you’re in for a treat. Kiva offers the same ratio of 5 mg THC and 2 mg CBN in their popular Terra chocolate bites. A crunchy chocolate cookie core is bathed in the creamiest of milk chocolate, with hints of vanilla and sea salt adding the finishing touches to these delectable bedtime wonders.

Petra Blackberry Mints

For a subtle blend of THC and CBN in a fresh format, Kiva provides their Petra Blackberry Mints. 2 mg THC and 1 mg CBN combine with blackberry and vanilla flavors for a refreshingly tranquil, sugar-free experience that’s perfect for power naps and those who love a lightly-dosed edible.

Find your best sleep with Kiva

With so many options to help support better sleep, Kiva makes it easier than ever to drift off with something delicious. Find the all-natural treat for all your slumbering needs at the link below.

Source link

ADD

Can Medical Marijuana Help During The Adderall Shortage

Published

3 weeks ago

April 2, 2024

admin

Roughly 2.6% (139.8 million) of adults worldwide some form of ADHD. With the Adderall shortage, what are the options?

In October 2022, the US Food and Drug Administration announced a shortage of Adderall. The issue has has not be resolved and now, it seems, it is starting to have a larger effect on patients. South America (11.8%) has highest rate and Japan and Finland the lowest. American about average (7%). The average monthly prescription fill rate was 11% lower in the first half of 2023 than it was in the first half of 2022, and it did not show steady signs of improvement through the end of 2023.

More research needs to be done, but can medical marijuana help during the Adderall Shortage – or in general? While scientists are still research cannabis and ADHD, there is some early data suggesting cannabis may be a helpful therapy.

Attention deficit hyperactivity disorder (ADHD) is a neurological condition which makes it difficult to focus and can lead to impulsivity and hyperactivity. ADHD is the official medical diagnosis, whereas Attention Deficit Disorder (ADD) is a now-outdated term that describes people with primarily inattentive symptoms.

While those diagnosed with ADHD may encounter trouble in school or work, most have gone on to lead successful lives. While there is no cure for ADHD, there are treatments that can help manage symptoms. Common treatments include medication, therapy, and lifestyle changes.

Can CBD Be Used To Treat ADHD Symptoms? — Photo by Katja Kircher/Getty Images

However, some people do not respond well to medication or cannot tolerate the side effects. As a result, many people turn to natural treatments like cannabis and CBD to treat their ADHD symptoms. Any medical marijuana given to someone under 21 should be discussed with a health care professional as the research is still out and the brain is still developing.

It is worth noting there is some inconclusive evidence suggesting CBD might be used as an adjunctive treatment in schizophrenia, and a few isolated studies show CBD’s efficacy in social anxiety.

Two ways data based ways medical marijuana can help with symptoms of ADHD are sleep issues and reducing anxiety. One of the most common reasons Americans use medical cannabis is to help with insomnia. Most people know what it is like trying to fall asleep when your mind is full of thoughts or concerns. Certain types of cannabis may help turn your busy brain into a blank board, allowing a solid night of sleep.

Another common medical reason is to manage anxiety and stress. But certain strains of cannabis produce the same anxiety symptoms, so you have to be careful about the type of medical cannabis you choose. Stimulating cannabis strains can have a calming effect on people with ADHD symptoms. When consumed responsibly, Sativa cannabis may help calm social anxiety while allowing you to remain focused, alert, and conversational.

If you have been diagnosed with ADHD, have an open, fact based discussion with your health care profession about blending medical marijuana into your treatment.

Source link

California

CBD + CBN Sleep Gummies—Kush Queen

Published

5 months ago

November 16, 2023

admin

92 points out of 100

Price: $25/a package of ten gummies

Founded by California budtender Olivia Alexander, the lauded CBD brand Kush Queen turns out some of the most impressive gummies in the market. Their Sleep Gummies each pack 15 milligrams of full-spectrum CBD and 15 milligrams of CBN, which consumers and business alike tout for its sedative properties, despite a dearth of scientific evidence.

The gummies highlight the company’s strengths: Stellar taste and quick-acting, powerful effects. Available exclusively in Mixed Berry, the gummies boast a pleasant chewiness and subtle flavor light years removed from some of their gelatin-heavy and over-sugared competitors; that being said, the gummy left a mildly filmy and unsavory aftertaste on the tongue.

It kicks into action quickly, too: Twenty minutes or so after I ate one after dinner, it induced a warm and gentle buzz. Shortly after that, it had me out cold for a superb night of sleep.

Note: Since Kush Queen products contain less than 0.3% THC, you can legally buy them through Kush Queen’s website and have them shipped to your home.

red gummies on black lid — Credit: Max Savage Levenson for Leafly

Never miss a rating: Subscribe to Leafly Newsletters, and download the Leafly App.

About our ratings

Leafly Ratings’ 100-Point Scale

95-100 Perfect: exemplary cannabis
90-94 Outstanding: a cannabis product of superior character and style
85-89 Very good: a weed with special qualities
80-84 Good: a solid, well-made weed
75-79 Mediocre: a smokeable weed that may have minor flaws
50-74 Not recommended

How we rate

Dried, cured, packaged, and sold buds, reviewed from bag in tastings, are given a single score. We focus on aroma, taste, effect, look, pedigree, cultivation method, and more.
Special Designations
Our editors focus on excellent, widely available ganja at a reasonable price. Special qualities include:

Top-shelf: It ain’t cheap, or necessarily plentiful, but it’s really good. Welcome to the top shelf.
Smart Buys: Fine, affordable, broadly available pot.

Leafly News cannabis ratings and ethics

Leafly News aims to retain and expand its expertise, authority, and trust.

Expertise is built through years of reviews, interviews with growers, visits to weed regions, and accumulated knowledge about cannabis horticulture, flavors, history, and culture. Leafly News’ editors and freelancers have a combined 50 years of experience with cannabis.
We aim to be accurate and independent, with policies including:

Actual tastings—If we didn’t smoke it, we’re not reviewing it. At Leafly Ratings, all ratings come from multiple tastings.
Independence—Leafly expert reviewers are paid by Leafly and are independent. We accept review samples with no promise of coverage. Leafly rating staff cannot accept bribes. We generally pay our own expenses and report on what the readers want to see.

Source link

2023 U.S. National Cannabinoid Report

Cannabinoids Bring in More Than Legal Markets

Published

6 months ago

November 7, 2023

admin

A new report by Whitney Economics highlights how the illegal cannabinoids industry, brings in more money than legal weed markets.

New report by Whitney Economics

The cannabinoids market came into being following the 2018 US Farm Bill, which legalized industrial hemp cultivation and production. It didn’t legalize the use of products for any kind of nutritional supplementation or food, or permit synthetic processing. Though federal congress has proposed laws for the former, nothing has gone through, and the FDA claims it cannot update this on its own. As such, its legal to produce hemp; but all hemp-derived cannabinoids (products that use hemp as a base material) are unregulated for internal use, and not part of legal markets.

Whitney Economics is a data and consulting operation in the weed and hemp space, which is based out of Portland, Oregon. It works with both government agencies and private enterprises, at both the state and federal levels; to help create workable economic strategies and policy, for related businesses and projects.

Earlier this year, Whitney made clear for the public, just how much the federal government takes indirectly in cannabis taxes, via Section 280E of the federal tax code. At that time, the company estimated that cannabis businesses had overpaid $1.8 billion in 2022 alone; with an expected increase to $2.1 billion for 2023. The company also said that in a survey of businesses from 2022, that only 24.4% of legal operators made a profit that year. Now, Whitney has some new news, and it might not be what regulators really want to hear.

cannabinoids can be directly extracted or hemp-derived

According to Whitney’s 2023 U.S. National Cannabinoid Report, which analyzed the impact of the hemp-derived cannabinoids industry on legal markets; hemp-derived weed sales outpaced every legal state market, in 2022. The report put sales for cannabinoids at about the level of craft beer sales in the country.

How much revenue did the cannabinoids market make, in 2022? Whitney estimates that CBD and other cannabinoids like delta-8 THC, brought in around $28.4 billion. Per the report, “For context, hemp-derived cannabinoid sales nationally were greater than total legal sales of medical and adult-use cannabis in 2022.”

It continues, “Currently, the total demand for hemp-derived cannabinoids is valued in excess of $28 billion and supports the employment of 328,000 workers, who earn $13 billion in wages. Overall, the total economic impact of the hemp-derived cannabinoid industry on the U.S. economy is in excess of $79 billion.” It also said that “While they may seem large, these estimates are actually conservative, because they do not account for demand and employment from gas stations, grocery stores and convenience stores.”

Why are we only hearing this now?

The report didn’t make a big deal about the term ‘black market,’ referring to it instead as ‘illicit.’ But the terms mean the same thing. The hemp-derived cannabinoids market is a black market, and no products in it are approved. While some products collect sales tax for governments, others are not scanned at all, or only for show. This means, no government has direct statistics of how large this (or any) black market is.

It’s not that we’re not being told the sales comparison, its because there isn’t one in hard numbers. And the unfortunate truth of gray areas in information, means that anything can be said. Think of all those headlines about how much money cannabis taxes bring in. Well, those amounts are far less than expected and hoped for, regardless of their hype. And we know this because of the sheer size of the black market; which indicates only a percentage of people use legal dispensaries.

To give a quick example on this one, consider that New York has had an operational market for the better part of a year. Yet it was reported in the spring (and then repeated in September) that the state only gave out about 60 licenses for legal establishments. And this while approximately 1,400 illicit stores exist. Just taking those numbers into account, (which is conservative given that the 60 licenses might not all be operational dispensaries yet); it becomes clear that the black market is way bigger, and therefore likely makes way more money.

Since governments don’t technically tax black markets, all we have are estimates. It should be noted that sales tax is applied to some products; but sin (excise) taxes uniformly are not, nor are THC taxes, cultivation taxes, or any other industry-specific taxes. Beyond this, no sales information is collected on most of these purchases.

The weed black market isn’t that different from the growing vape market; most of which functions outside of regulation. This applies to both disposable vapes, as well as other non-disposable products. While we once gain don’t have direct numbers to compare sales, we can consider the following: Grand View Research estimated just the disposable market brought in close to $6 billion in 2021, with an expected yearly growth rate of over 11% until 2030.

It was also estimated that 9,000+ vape products are on the market in the US, and nearly 40% are disposables. As no disposables are legal, this indicates automatically at least 40% of the market is illegal. Seeing as how governments apparently approved less than 1% of vape product applications, the illicit number could be closer to 90%+. We’re never told about this in terms of a lack of government revenue; instead, the public hears about it as fear campaigns meant to dissuade it from buying certain products.

What Whitney report tells us about cannabinoids and legal markets?

The report helps put into perspective, the actual situation at hand. It pops the balloon of reporting that seeks to claim the legal markets are sky-rocketing in success. Realistically, we know this can’t be true due to all the issues with broke cultivators, overproduction, layoffs, and lowered product prices despite high taxes and regulatory fees. We can know it logically by these discrepancies; but a report like this shines a light on the issue.

The report makes clear that lawmakers should consider the size of this hemp-derived market when making regulatory decisions. Report author Beau Whitney explained to Marijuana Moment that legal market regulators “do not have the data on how large the market is and the large number of consumers that prefer this over adult-use and medical. The result is large labor displacement and increased business failures.”

Whitney continued that regulators should look to embrace this market, rather than try to destroy it, saying “It was unfortunate that ‘big cannabis’ is villainizing the hemp industry, when they are making hundreds of million of dollars in revenue from the sale of these very same hemp-derived products.”

He goes on that “We at Whitney Economics feel that the adult-use and medical markets should support the hemp distribution model as it allows for widespread distribution for cannabinoids. If adult-use and medical would follow this path, there would be massive opportunities for growers, processors and manufacturers and would make a significant dent into illicit sales (through greater access and greater legal consumer participation).”

As in, if the legal markets really want to fight the black market, and divert more sales to legal vendors; they must be competitive with it. He’s saying, the popularity of hemp-derived products shouldn’t be ignored, as this can inform future sales. According to the report’s Executive Summary:

“Federal regulation was not able to keep pace with the rapid deployment of hemp products on the market. While mostly self-regulated (with the exception of the cultivation of hemp), concerns arose over the potential intoxicating effect of some cannabinoid products, and the potential public safety risks associated with intoxication. State legislatures attempted to intervene and provide regulatory structure to the industry, but those efforts have generated several unintended consequences on the industry.”

It then explains, “In order to address these issues, policy makers at all levels require data. Up to this point, there has not been a comprehensive, national assessment of the hemp-derived cannabinoid industry. Whitney Economics has taken a conservative approach to data gathering and projections. The intention of this report is to provide a baseline of data in order to help hemp industry stakeholders understand the level of economic activity associated with hemp cannabinoids, and the impact that policy changes will have on the future.”

Conclusion

Weed black markets – including the cannabinoids industry, are a huge source of competition for legal markets. I expect these figures relate to black market sales in general, and include non-hemp-derived products sold by black market pharmacies; although I cannot confirm this. It shouldn’t be shocking that governments will likely ignore all of it, though. Let’s be honest, they already know the situation; and that hasn’t led to legislation that makes sense. Given this repeated history across states, it’s genuinely hard to believe this report will change anything.

Thanks for joining us today. Welcome to Cannadelics.com; an independent rag, covering the drugs world at large, with a focus on cannabis and hallucinogens. We’re here everyday, so come by frequently to visit; and head over to the Cannadelics Weekly Newsletter; for the best product offers in conjunction with the news.